External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ACR 2020

-
Coming soon
04:20 PM
Duration 10mins Virtual
Characteristics of Giant Cell Arteritis Flares After Successful Treatment With Tocilizumab: Results From the Long-Term Extension of a Randomized Controlled Phase 3 Trial
Unizony Sebastian, Mohan Shalini, Han Jian, Stone John

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:00 PM
Duration 10mins Virtual
Two-Year Results from a Randomized, Controlled Study of Obinutuzumab for Proliferative Lupus Nephritis
Furie R, Aroca G, Alvarez A, Fragoso-Loyo H, Santillán EZ, Rovin BH, Brunetta P, Schindler T, Hassan I, Cascino MD, Garg JP, Malvar A

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar